Vulnerability Description
The diagnosticsb2ksy parameter of the /rest endpoint in Opsview Monitor before 5.3.1 and 5.4.x before 5.4.2 is vulnerable to Cross-Site Scripting.
CVSS Score
6.1
MEDIUM
CVSS:3.0/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Opsview | Opsview | < 5.3.1 |
Related Weaknesses (CWE)
References
- https://knowledge.opsview.com/v5.3/docs/whats-newRelease NotesVendor Advisory
- https://knowledge.opsview.com/v5.4/docs/whats-newRelease NotesVendor Advisory
- https://seclists.org/fulldisclosure/2018/Sep/3ExploitMailing ListThird Party Advisory
- https://www.coresecurity.com/advisories/opsview-monitor-multiple-vulnerabilitiesExploitThird Party Advisory
- https://knowledge.opsview.com/v5.3/docs/whats-newRelease NotesVendor Advisory
- https://knowledge.opsview.com/v5.4/docs/whats-newRelease NotesVendor Advisory
- https://seclists.org/fulldisclosure/2018/Sep/3ExploitMailing ListThird Party Advisory
- https://www.coresecurity.com/advisories/opsview-monitor-multiple-vulnerabilitiesExploitThird Party Advisory
FAQ
What is CVE-2018-16148?
CVE-2018-16148 is a vulnerability with a CVSS score of 6.1 (MEDIUM). The diagnosticsb2ksy parameter of the /rest endpoint in Opsview Monitor before 5.3.1 and 5.4.x before 5.4.2 is vulnerable to Cross-Site Scripting.
How severe is CVE-2018-16148?
CVE-2018-16148 has been rated MEDIUM with a CVSS base score of 6.1/10. Review the CVSS metrics above for detailed severity breakdown.
Is there a patch for CVE-2018-16148?
Check the references section above for vendor advisories and patch information. Affected products include: Opsview Opsview.